BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Total Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹176 Cr | ₹153 Cr | ₹148 Cr | ₹130 Cr | ₹90 Cr |
What is the latest Total Liabilities ratio of BAFNA PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹176 Cr |
| Mar2025 | ₹153 Cr |
| Mar2024 | ₹148 Cr |
| Mar2023 | ₹130 Cr |
| Mar2022 | ₹90 Cr |
How is Total Liabilities of BAFNA PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹176 Cr | 14.67 | |
| Mar2025 | ₹153 Cr | 3.65 | |
| Mar2024 | ₹148 Cr | 13.97 | |
| Mar2023 | ₹130 Cr | 43.75 | |
| Mar2022 | ₹90 Cr | - | |
Compare Total Liabilities of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹1,114.5 Cr | -1% | 2.5% | 195.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,299.0 Cr | 1% | 7.5% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹297,325.0 Cr | 0.8% | 22.8% | 71.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,727.0 Cr | 0.2% | 1.9% | 20.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,145.0 Cr | 0.8% | 12.2% | 12.3% | Stock Analytics | |
| CIPLA | ₹114,312.0 Cr | 1.5% | 6.4% | -7.8% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | -1% |
2.5% |
195.9% |
| SENSEX | 2.9% |
13.9% |
-0.8% |
You may also like the below Video Courses